Combination therapy in type 2 diabetes mellitus: adding empagliflozin to basal insulin
Type 2 diabetes mellitus (T2DM) management is complex, with few patients successfully achieving recommended glycemic targets with monotherapy, most progressing to combination therapy, and many eventually requiring insulin. Sodium glucose cotransporter 2 (SGLT2) inhibitors are an emerging class of an...
| Main Author: | |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Just Medical Media Limited
2015
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4654596/ |